Gain Therapeutics GANX
NASDAQ GANX
$1.26 -0.03 (-2.33%)
At close: Oct 23, 2026 · 4:00 PM EDT

Gain Therapeutics (GANX) Purchase of Investments (2022 - 2023)

Updated

Analysis

Gain Therapeutics (GANX) Purchase of Investments (2022 - 2023) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Investments Purchased (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn 307.00 Mn
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 919.00 Mn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn 834.00 Mn
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn 148.00 Mn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 46.00 Mn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn -
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn -
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn 42.00 Mn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 2.54 Bn
10 Gain Therapeutics 54.61 Mn -4.68 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2023 1.96 Mn
Dec 31, 2022 1.93 Mn
Sep 30, 2022 959,179.00
API Access

Gain Therapeutics Purchase of Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=purchase-of-investments&ticker=GANX&period=max&api_key=YOUR_API_KEY